GMR Solutions Inc

Análisis de la acción GMR Solutions Inc (GMRS)

$9.980

-0.020 (-0.20%)Al cierre

Loading chart…
Máximo
10.090
Apertura
9.980
Precio medio ponderado por volumen
9.94
Volumen
371.53K
Capitalización
—
Mínimo
9.750
Importe
3.69M
EV/EBITDA, TTM
7.23

GMR Solutions Inc. is a provider of emergency medical services and integrated providers of essential alternate-site, out-of-hospital care in the United States and mobile clinical practice groups globally. It maintains longstanding relationships across the healthcare ecosystem, serving local communities, health systems, payors, public health and local, state and federal agencies. Its emergent care services include rapid, clinically appropriate responses, lifesaving critical interventions and, when necessary, transport to the next site of care. Its non-emergent care services include scheduled and non-emergency patient care. Together with its professional pilots, mechanics, communications specialists and other operational support roles, it delivers comprehensive care across a range of time-sensitive patient conditions, from cardiac arrests, strokes and significant traumatic injuries to acute behavioral health episodes, toxic exposures, and emergent in-the-field newborn deliveries.

Análisis de IA of GMR Solutions Inc (GMRS)

Vender

GMR Solutions Inc. is not a good buy right now due to significant recent losses and negative earnings performance. The stock is currently priced at $10.00, down 33.33% year-to-date, and has an RSI of 34.449, indicating it is oversold. Additionally, the company reported a net income loss of $28.3 million in Q2 2026, compared to a profit of $80.8 million in Q2 2025, which raises concerns about its financial health. The main risk is the company's high debt-to-equity ratio of 571.93%, which could hinder its ability to recover.

Métricas de valoración

El PER previsto actual de GMR Solutions Inc (GMRS) es 0.00, frente a su media de 5 años de .

PER previsto

Media 5A P/E
P/E actual
0.00

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
6.23
EV/EBITDA actual
7.23
Sobrevalorada
7.71
Infravalorada
4.75

Precio/ventas previsto

Infravalorado
Media 5A P/S
0.11
P/S actual
0.09
Sobrevalorada
0.12
Infravalorada
0.10

Ballenas con GMRS en cartera

T

The Olayan Group

+ Con en carteraGMRS

+4.89%

Rentabilidad a 3 meses

K

KKR & Co. Inc.

+ Con en carteraGMRS

-1.27%

Rentabilidad a 3 meses

Cronología de eventos

2026-08-12 (ET)

17:00:00

GMR Reports Q2 Revenue of $1.49B, Exceeds Expectations

2026-07-08 (ET)

09:00:00

GMR Solutions Appoints New Board Members

2026-06-08 (ET)

11:50:00

Quantum Computing Company Quantinuum Prices IPO at $60

2026-06-01 (ET)

16:50:00

GMR Reports Q1 Revenue of $1.46B

2026-05-13 (ET)

13:40:00

GMR Solutions Prices 31.91M Shares at $15.00

Noticias

Preguntas frecuentes sobre GMRS, respondidas por Alphio AI

GMR Solutions Inc. is a provider of emergency medical services and integrated providers of essential alternate-site, out-of-hospital care in the United States and mobile clinical practice groups globally. It maintains longstanding relationships across the healthcare ecosystem, serving local communities, health systems, payors, public health and local, state and federal agencies. Its emergent care services include rapid, clinically appropriate responses, lifesaving critical interventions and, when necessary, transport to the next site of care. Its non-emergent care services include scheduled and non-emergency patient care. Together with its professional pilots, mechanics, communications specialists and other operational support roles, it delivers comprehensive care across a range of time-sensitive patient conditions, from cardiac arrests, strokes and significant traumatic injuries to acute behavioral health episodes, toxic exposures, and emergent in-the-field newborn deliveries. It operates in the Healthcare sector.

GMR Solutions Inc. is not a good buy right now due to significant recent losses and negative earnings performance. The stock is currently priced at $10.00, down 33.33% year-to-date, and has an RSI of 34.449, indicating it is oversold. Additionally, the company reported a net income loss of $28.3 million in Q2 2026, compared to a profit of $80.8 million in Q2 2025, which raises concerns about its financial health. The main risk is the company's high debt-to-equity ratio of 571.93%, which could hinder its ability to recover.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar